Cargando…

Seroprevalence of antibodies to primate erythroparvovirus 1 (B19V) in Australia

BACKGROUD: Primate erythroparvovirus 1 (B19V) is a globally ubiquitous DNA virus. Infection results in a variety of clinical presentations including erythema infectiosum in children and arthralgia in adults. There is limited understanding of the seroprevalence of B19V antibodies in the Australian po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faddy, Helen M., Gorman, Elise C., Hoad, Veronica C., Frentiu, Francesca D., Tozer, Sarah, Flower, R. L. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286569/ https://www.ncbi.nlm.nih.gov/pubmed/30526514 http://dx.doi.org/10.1186/s12879-018-3525-7

Ejemplares similares

Primate Erythroparvovirus 1 Infection in Patients with Hematological Disorders
por: Krumova, Stefka, et al.
Publicado: (2022)

A Conserved Receptor-Binding Domain in the VP1u of Primate Erythroparvoviruses Determines the Marked Tropism for Erythroid Cells
por: Bircher, Cornelia, et al.
Publicado: (2022)

Estimation of mosquito-borne and sexual transmission of Zika virus in Australia: Risks to blood transfusion safety
por: Viennet, Elvina, et al.
Publicado: (2020)

Past and future epidemic potential of chikungunya virus in Australia
por: White, Timothy, et al.
Publicado: (2021)

Epidemic Potential for Local Transmission of Zika Virus in 2015 and 2016 in Queensland, Australia
por: Viennet, Elvina, et al.
Publicado: (2016)

Detection of coinfection with Primate Erythroparvovirus 1 and arboviruses (DENV, CHIKV and ZIKV) in individuals with acute febrile illness in the state of Rio Grande do Norte in 2016
por: Morais, Vanessa dos Santos, et al.
Publicado: (2023)

In silico Analysis of Genetic Diversity of Human Hepatitis B Virus in Southeast Asia, Australia and New Zealand
por: Phan, Ngoc Minh Hien, et al.
Publicado: (2020)

Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia
por: McVernon, Jodie, et al.
Publicado: (2014)

El Niño Southern Oscillation, overseas arrivals and imported chikungunya cases in Australia: A time series analysis
por: Huang, Xiaodong, et al.
Publicado: (2019)

SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA
por: Flower, Barnaby, et al.
Publicado: (2020)

Hepatitis E virus: do locally acquired infections in Australia necessitate laboratory testing in acute hepatitis patients with no overseas travel history?
por: Shrestha, Ashish C., et al.
Publicado: (2015)

Hepatitis E virus seroepidemiology: a post-earthquake study among blood donors in Nepal
por: Shrestha, Ashish C., et al.
Publicado: (2016)

The seroprevalence of SARS‐CoV‐2‐specific antibodies in children, Australia, November 2020 – March 2021
por: Koirala, Archana, et al.
Publicado: (2022)

Mitigating the Risk of Transfusion-Transmitted Dengue in Australia
por: Rooks, Kelly, et al.
Publicado: (2016)

Endemicity of Yaws and Seroprevalence of Treponema pallidum Antibodies in Nonhuman Primates, Kenya
por: Zimmerman, Dawn M., et al.
Publicado: (2019)

Hepatitis E Virus and Implications for Blood Supply Safety, Australia
por: Shrestha, Ashish C., et al.
Publicado: (2014)

Implications of Dengue Outbreaks for Blood Supply, Australia
por: Faddy, Helen M., et al.
Publicado: (2013)

Dynamic spatiotemporal trends of imported dengue fever in Australia
por: Huang, Xiaodong, et al.
Publicado: (2016)

Human Herpesvirus 8 in Australia: DNAemia and Cumulative Exposure in Blood Donors
por: Speicher, David J., et al.
Publicado: (2022)

Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients
por: Del Zompo, Fabio, et al.
Publicado: (2021)

Epidemiology of dengue in a high-income country: a case study in Queensland, Australia
por: Viennet, Elvina, et al.
Publicado: (2014)

No Increase in Out-of-Hospital Cardiac Arrests During the COVID-19 Pandemic, Despite Reduction in Acute Coronary Syndrome in NSW, Australia
por: Madronio, C., et al.
Publicado: (2021)

A Comparative Study of Assay Performance of Commercial Hepatitis E Virus Enzyme-Linked Immunosorbent Assay Kits in Australian Blood Donor Samples
por: Shrestha, Ashish C., et al.
Publicado: (2016)

Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2
por: Dong, Qunfeng, et al.
Publicado: (2020)

Kinetics and seroprevalence of SARS-CoV-2 antibodies in children
por: Roarty, Cathal, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in South Korea
por: Lee, Kwangmin, et al.
Publicado: (2021)

An Outbreak of Japanese Encephalitis Virus in Australia; What Is the Risk to Blood Safety?
por: Hoad, Veronica C., et al.
Publicado: (2022)

Vector competence of Australian Aedes aegypti and Aedes albopictus for an epidemic strain of Zika virus
por: Hugo, Leon E., et al.
Publicado: (2019)

High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts
por: Naranbhai, Vivek, et al.
Publicado: (2020)

Low Genetic Diversity of Hepatitis B Virus Surface Gene amongst Australian Blood Donors
por: Phan, Ngoc Minh Hien, et al.
Publicado: (2021)

Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy
por: Ferrari, Martina, et al.
Publicado: (2023)

SARS-CoV-2 seroprevalence in healthcare workers in a tertiary healthcare network in Victoria, Australia
por: Lau, Jillian SY, et al.
Publicado: (2021)

Estimated seroprevalence of SARS-CoV-2 antibodies among adults in Orange County, California
por: Bruckner, Tim A., et al.
Publicado: (2021)

Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in Cyprus
por: Papaneophytou, Christos, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands
por: Petersen, Maria Skaalum, et al.
Publicado: (2020)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Nazemipour, Maryam, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Ghafari, Mahan, et al.
Publicado: (2021)

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
por: Reicher, Shay, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in radio and television workers
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2022)

Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022
por: Clarke, Kristie E.N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nios020cgvcepl0ahfeq1aiii9